Skip to main content

JUUL Gets Preliminary Court Approval Over Vape Suits

JUUL Gets Preliminary Court Approval Over Vape Suits

JUUL Gets Preliminary Court Approval Over Vape Suits

Introduction

As the business attempts to settle hundreds of cases, Juul Labs Inc obtained preliminary court approval of a $255 million deal, settling customer accusations that it falsely promoted e-cigarettes.

According to a court filing, the proposed class action settlement settling claims by users who claimed they overpaid for Juul's vaping devices was fair, reasonable, and appropriate.

The payment is part of Juul's wider global agreement to settle hundreds of claims filed by school districts, local governments, and individuals accusing the company of contributing to a juvenile vaping pandemic.

Last month, the corporation said that it had negotiated settlements with about 10,000 claimants in over 5,000 instances. It has not stated how much it would pay, but sources claim that the transaction is worth $1.7 billion.

The class action settlement resolves claims by customers who allege they would have spent less or not purchased the e-cigarettes at all if Juul had not minimised the devices' addictiveness and marketed to youths via social media ads and other ways. A request for comment from Juul was not returned.

Juul, which is owned in part by Marlboro manufacturer Altria Group Inc, agreed in September to pay $438.5 million to resolve charges from 34 U.S. states and territories that the firm targeted underage buyers and downplayed the hazards of its products.

The Food and Drug Administration temporarily banned Juul's e-cigarettes in June, but the rule was eventually reversed after an appeal.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!